@jpmkane.bsky.social
📤 182
📥 146
📝 25
Passionate about neuroscience? 🧠 We’re recruiting a PhD student to join INSPECT-DLB - improving the diagnosis of dementia with Lewy bodies. Work at QUB with
@ecebayram.bsky.social
, Dr Claire McEvoy, me & team on this @lewybodysociety.bsky.social-funded project. 🔗
tinyurl.com/yck7466a
loading . . .
Investigating the specificity and primary predictive value of the clinical diagnostic criteria for dementia with Lewy bodies (DLB) (InSpecT-DLB) at Queen’s University Belfast on FindAPhD.com
PhD Project - Investigating the specificity and primary predictive value of the clinical diagnostic criteria for dementia with Lewy bodies (DLB) (InSpecT-DLB) at Queen’s University Belfast, listed on ...
https://www.findaphd.com/phds/project/investigating-the-specificity-and-primary-predictive-value-of-the-clinical-diagnostic-criteria-for-dementia-with-lewy-bodies-dlb-inspect-dlb/?p186942
2 months ago
0
1
2
We are counting down for
#AAIC25
and to catch up with our
#LBDPIA
members in person 😍 As we wait patiently, we prepared a webpage for you to find us, check out our work and join our team:
sites.google.com/view/lbdpia-...
4 months ago
0
1
0
🎓 Are you an early-career researcher in
#LewyBodyDementia
? Join us at Lewy Connect, hosted by LBDA at
#AAIC2025
! 🗓️ July 29, 6–8pm 📍 InterContinental Toronto Centre 🔗 Network, meet LBD leaders, build your career! RSVP now—space is limited! 👇
doodle.com/sign-up-shee...
loading . . .
Doodle
Doodle is the simplest way to schedule meetings with clients, colleagues, or friends. Find the best time for one-to-ones and team meetings with our user-friendly calendar tool. Get started today!
https://doodle.com/sign-up-sheet/participate/47ccd744-bdd2-4021-8529-b6cbaac53bf5/select
4 months ago
0
2
0
There’s a lot of DLB research happening, but what are we actually asking people with DLB and their care partners? Which perspectives are we missing?
@qubelfastofficial.bsky.social
PhD candidate Paula Sinéad Donnelly leads this insightful scoping review👇
alzres.biomedcentral.com/articles/10....
loading . . .
Research on the perspectives of people affected by dementia with Lewy bodies: a scoping review - Alzheimer's Research & Therapy
Background Dementia with Lewy bodies (DLB) is associated with specific challenges, including heterogeneity in clinical presentation and a less favourable prognosis relative to other dementia subtypes....
https://alzres.biomedcentral.com/articles/10.1186/s13195-025-01760-4
6 months ago
0
0
0
Last week
@qubelfastofficial.bsky.social
we were delighted to host Dr Yuto Satake from Osaka University and
@ucl.ac.uk
to discuss his work on AD & DLB biomarkers, very late onset psychosis and tackling loneliness with SoTa the robot. Come back soon Yuto!
6 months ago
0
1
0
We were joined today by attendees from FORTY-SIX countries! 🇦🇫 🇦🇽 🇩🇿 🇦🇴 🇦🇷 🇦🇿 🇧🇷 🇧🇳 🇧🇫 🇨🇦 🇨🇱 🇨🇳 🇨🇴 🇨🇿 🇪🇬 🇬🇪 🇩🇪 🇬🇭 🇬🇷 🇭🇰 🇮🇳 🇮🇩 🇮🇪 🇰🇪 🇲🇹 🇲🇺 🇲🇲 🇳🇬 🇵🇰 🇵🇪 🇵🇭 🇸🇦 🇸🇬 🇿🇦 🇪🇸 🇱🇰 🇸🇪 🇹🇼 🇹🇭 🇹🇹 🇹🇳 🇹🇷 🇬🇧 🇺🇸 🇻🇪 🇻🇳
add a skeleton here at some point
6 months ago
0
2
1
reposted by
Ece Bayram
8 months ago
📢📢
@istaart.bsky.social
#DemenciaConCuerposDeLewy
Seminario de Casos Clínicos en español tendrá lugar el 13 de mayo,10am US CT📢📢
#LBDPIA
vicepresidente
@frodriguezporcel.bsky.social
moderará con oradores fabulosos Ceci Fernandez,Ruth Agnew&Fernando Garcia Regístrate!
alz-org.zoom.us/webinar/regi...
0
3
2
Fantastic to host today's
@istaart.bsky.social
#LBDPIA
Clinical Case Review webinar, with presentations from Dra. Cecilia Fernández & Drs Agnew, Garcia & Barton from
@belfasttrust.bsky.social
. Tomorrow's webinar will discuss the same cases in Spanish - register here
istaart.alz.org/events/item/...
6 months ago
0
4
4
Genial haber sido anfitrión del seminario web de Revisión de Casos Clínicos
@istaart.bsky.social
#LBDPIA
de hoy con Dra. Cecilia Fernández y Drs. Agnew, Garcia y Barton de
@belfasttrust.bsky.social
. Regístrate aquí para nuestro seminario web en español mañana:
istaart.alz.org/events/item/...
6 months ago
0
1
0
reposted by
Lincoln Michel
9 months ago
Don't let anyone tell you that you can't live your dreams
1
1653
309
reposted by
ISTAART
10 months ago
ISTAART is on Bluesky! Follow us as we discuss the latest in research and treatment and make connections to grow the global dementia science community.
0
11
7
#AAIC25
is Canada-bound 🇨🇦 Abstract and session proposals can now be submitted at
aaic.alz.org
12 months ago
0
0
0
@kaanthanj.bsky.social
the profile pic 😂😂😂
about 1 year ago
1
1
0
@carlaabdelnour.bsky.social
bienvenida Carla!
about 1 year ago
1
1
0
@rikossenkoppele.bsky.social
welcome Rik!
about 1 year ago
0
1
0
about 1 year ago
0
2
0
reposted by
Susan Kohlhaas
about 1 year ago
📣 Breaking News European Medicines Agency has decided to approve lecanemab for early Alzheimer’s with some restrictions. This follows and mirrors a positive MHRA decision earlier in the year. These treatments are modest at best but do represent some progress were making in Alzheimer’s research.
1
4
3
EU medicines agency has revised its initial verdict on lecanemab in (non ApoE4 homozygous) Alzheimer’s disease - recommending authorisation to EU bodies
www.ema.europa.eu/en/news/leqe...
loading . . .
Leqembi recommended for treatment of early Alzheimer’s disease | European Medicines Agency (EMA)
Re-examination concludes that benefits outweigh risks in a restricted patient population
https://www.ema.europa.eu/en/news/leqembi-recommended-treatment-early-alzheimers-disease
about 1 year ago
0
1
0
A summary of EPIC training.
about 1 year ago
0
0
0
about 1 year ago
0
1
0
you reached the end!!
feeds!
log in
